Direct Oral Anticoagulants and Interstitial Lung Disease: Emerging Clues from Pharmacovigilance

Detalles Bibliográficos
Autores principales: Raschi, Emanuel, Fusaroli, Michele, Diemberger, Igor, Poluzzi, Elisabetta
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2020
Materias:
Research Letter
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7447592/
https://www.ncbi.nlm.nih.gov/pubmed/32845443
http://dx.doi.org/10.1007/s40264-020-00990-9
_version_ 1783574332323135488
author Raschi, Emanuel
Fusaroli, Michele
Diemberger, Igor
Poluzzi, Elisabetta
author_facet Raschi, Emanuel
Fusaroli, Michele
Diemberger, Igor
Poluzzi, Elisabetta
author_sort Raschi, Emanuel
collection PubMed
description
format Online
Article
Text
id pubmed-7447592
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Springer International Publishing
record_format MEDLINE/PubMed
spelling pubmed-74475922020-08-26 Direct Oral Anticoagulants and Interstitial Lung Disease: Emerging Clues from Pharmacovigilance Raschi, Emanuel Fusaroli, Michele Diemberger, Igor Poluzzi, Elisabetta Drug Saf Research Letter Springer International Publishing 2020-08-26 2020 /pmc/articles/PMC7447592/ /pubmed/32845443 http://dx.doi.org/10.1007/s40264-020-00990-9 Text en © Springer Nature Switzerland AG 2020 This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic.
spellingShingle Research Letter
Raschi, Emanuel
Fusaroli, Michele
Diemberger, Igor
Poluzzi, Elisabetta
Direct Oral Anticoagulants and Interstitial Lung Disease: Emerging Clues from Pharmacovigilance
title Direct Oral Anticoagulants and Interstitial Lung Disease: Emerging Clues from Pharmacovigilance
title_full Direct Oral Anticoagulants and Interstitial Lung Disease: Emerging Clues from Pharmacovigilance
title_fullStr Direct Oral Anticoagulants and Interstitial Lung Disease: Emerging Clues from Pharmacovigilance
title_full_unstemmed Direct Oral Anticoagulants and Interstitial Lung Disease: Emerging Clues from Pharmacovigilance
title_short Direct Oral Anticoagulants and Interstitial Lung Disease: Emerging Clues from Pharmacovigilance
title_sort direct oral anticoagulants and interstitial lung disease: emerging clues from pharmacovigilance
topic Research Letter
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7447592/
https://www.ncbi.nlm.nih.gov/pubmed/32845443
http://dx.doi.org/10.1007/s40264-020-00990-9
work_keys_str_mv AT raschiemanuel directoralanticoagulantsandinterstitiallungdiseaseemergingcluesfrompharmacovigilance
AT fusarolimichele directoralanticoagulantsandinterstitiallungdiseaseemergingcluesfrompharmacovigilance
AT diembergerigor directoralanticoagulantsandinterstitiallungdiseaseemergingcluesfrompharmacovigilance
AT poluzzielisabetta directoralanticoagulantsandinterstitiallungdiseaseemergingcluesfrompharmacovigilance

Ejemplares similares